January 6, 2013
A new drug for the treatment of Secondary Progressive Multiple Sclerosis (SPMS) called MIS416, developed by New Zealand biopharmaceutical company Innate Immunotherapeutics, has been granted a patent in the United States
- /
- /
- /
Auckland, New Zealand December 18 2012: A new drug for the treatment of secondary progressive multiple sclerosis (SPMS) called MIS416,…